Continued Regulatory Guidance on Pharmacovigilance: Aligning with Best Practices and Data Transparency in 2026
The pharmacovigilance (PV) landscape is evolving rapidly, triggered by increasing data volumes, global collaborative efforts, and demanding data transparency expectations. Given the scenario, 2026 is expected to become a defining year for the Pharmaceutical industry
Read More